Back to Trades
Total Value
$107.9K
Net $107.9K sold
Filing Date
Jun 25, 2026
1 transaction
Sales
$107.9K
1 transaction
Trade Summary
On Jun 25, 2026, Hansen Gwenn, Chief Scientific Officer, sold $107.9K of Nurix Therapeutics, Inc. (NRIX) across 1 transaction. The filing covers Common Stock and reflects net selling of $107.9K. Reported prices ranged from $20.00. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Nurix Therapeutics, Inc.
- Ticker Symbol
- NRIX
- CIK
- 0001549595
Insider Information
- Name
- Hansen Gwenn
- Role
- Chief Scientific Officer
- Location
- BRISBANE, CA
Filing Details
- Filing Date
- Jun 25, 2026
- Transaction Date
- Jun 25, 2026
- Accession Number
- 0001817160-26-000010
- Form Type
- 4
- Net Trading Amount
- -$107.9K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 25, 2026 | Common Stock | 5,394 | $20.00 | Sale | $107.9K |
Want live alerts when Hansen Gwenn trades again?
Download Insider Trades to track NRIX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.